Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: A single-voxel 1H spectroscopy study

Schizophrenia Research

Volumn 93, Issue 1-3, 2007, Pages 23-32

  Stanley, Jeffrey A ^a,b   Vemulapalli, Madhuri ^b   Nutche, Jeffrey ^b   Montrose, Debra M ^b   Sweeney, John A ^c   Pettegrew, Jay W ^b   MacMaster, Frank P ^a   Keshavan, Matcheri S ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Dorsal lateral prefrontal cortex; Proton magnetic resonance spectroscopy; Schizophrenia

Indexed keywords

N ACETYLASPARTIC ACID; PROTON;

ADULT; APPARATUS; ARTICLE; BRAIN LEVEL; CELL PROLIFERATION; DENDRITE; FEMALE; GENDER; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NERVE CELL; NEUROIMAGING; ONSET AGE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SYNAPSE;

ADULT; AGE OF ONSET; ASPARTIC ACID; CELL DIVISION; DENDRITES; DOMINANCE, CEREBRAL; FEMALE; FRONTAL LOBE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEURONS; REFERENCE VALUES; SCHIZOPHRENIA; SYNAPSES;

EID: 34249277055     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.03.028     Document Type: Article

References (67)

1. Abbott C., and Bustillo J. What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update. Curr. Opin. Psychiatry 19 (2006) 135-139
2. Alaghband-Rad J., McKenna K., Gordon C.T., Albus K.E., Hamburger S.D., Rumsey J.M., Frazier J.A., Lenane M.C., and Rapoport J.L. Childhood-onset schizophrenia: the severity of premorbid course. J. Am. Acad. Child Adolesc. Psych. 34 (1995) 1273-1283
3. Alda M., Ahrens B., Lit W., Dvorakova M., Labelle A., Zvolsky P., and Jones B. Age of onset in familial and sporadic schizophrenia. Acta Psychiatr. Scand. 93 (1996) 447-450
4. Ambrosini P.J., Metz C., Prabucki K., and Lee J.C. Videotape reliability of the third revised edition of the K-SADS. J. Am. Acad. Child Adolesc. Psych. 28 (1989) 723-728
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (1994), American Psychiatric Association, Washington, D.C.
6. Asarnow J.R., Tompson M.C., and Goldstein M.J. Childhood-onset schizophrenia: a followup study. Schizophr. Bull. 20 (1994) 599-617
7. Badura F., Trott G.E., Mehler-Wex C., Scheuerpflug P., Hofmann E., Warmuth-Metz M., Nadjmi M., Solymosi L., and Warnke A. A study of cranial computer tomograms in very early and early onset schizophrenia. J. Neural Transm. 108 (2001) 1335-1344
8. Barch D.M., Carter C.S., Braver T.S., Sabb F.W., MacDonald III A., Noll D.C., and Cohen J.D. Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch. Gen. Psychiatry 58 (2001) 280-288
9. Bartha R., al-Semaan Y.M., Williamson P.C., Drost D.J., Malla A.K., Carr T.J., Densmore M., Canaran G., and Neufeld R.W. A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients. Biol. Psychiatry 45 (1999) 1403-1411
10. Baslow M.H. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem. Res. 28 (2003) 941-953
11. Bertolino A., Nawroz S., Mattay V.S., Barnett A.S., Duyn J.H., Moonen C.T., Frank J.A., Tedeschi G., and Weinberger D.R. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry 153 (1996) 1554-1563
12. Bertolino A., Callicott J.H., Elman I., Mattay V.S., Tedeschi G., Frank J.A., Breier A., and Weinberger D.R. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol. Psychiatry 43 (1998) 641-648
13. Bertolino A., Kumra S., Callicott J.H., Mattay V.S., Lestz R.M., Jacobsen L., Barnett I.S., Duyn J.H., Frank J.A., Rapoport J.L., and Weinberger D.R. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry 155 (1998) 1376-1383
14. Bertolino A., Sciota D., Brudaglio F., Altamura M., Blasi G., Bellomo A., Antonucci N., Callicott J.H., Goldberg T.E., Scarabino T., Weinberger D.R., and Nardini M. Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder. Am. J. Psychiatry 160 (2003) 483-489
15. Bettes B.A., and Walker E. Positive and negative symptoms in psychotic and other psychiatrically disturbed children. J. Child Psychol. Psychiatry 28 (1987) 555-568
16. Bhakoo K.K., and Pearce D. In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J. Neurochem. 74 (2000) 254-262
17. 1H MRS study of dorso-lateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology 29 (2004) 1918-1924
18. Brooks W.M., Hodde-Vargas J., Vargas L.A., Yeo R.A., Ford C.C., and Hendren R.L. Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study. Biol. Psychiatry 43 (1998) 263-269
19. Bustillo J.R., Rowland L.M., Lauriello J., Petropoulos H., Hammond R., Hart B., and Brooks W.M. High choline concentrations in the caudate nucleus in antipsychotic-naive patients with schizophrenia. Am. J. Psychiatry 159 (2002) 130-133
20. Cecil K.M., Lenkinski R.E., Gur R.E., and Gur R.C. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia. Neuropsychopharmacology 20 (1999) 131-140
21. Chakraborty G., Mekala P., Yahya D., Wu G., and Ledeen R.W. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J. Neurochem. 78 (2001) 736-745
22. Choe B.Y., Suh T.S., Shinn K.S., Lee C.W., Lee C., and Paik I.H. Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy. Invest. Radiol. 31 (1996) 345-352
23. Church S.M., Cotter D., Bramon E., and Murray R.M. Does schizophrenia result from developmental or degenerative processes?. J. Neural Transm., Suppl. (2002) 129-147
24. Cornblatt B.A., Lencz T., Smith C.W., Correll C.U., Auther A.M., and Nakayama E. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr. Bull. 29 (2003) 633-651
25. DeLisi L.E. The significance of age of onset for schizophrenia. Schizophr. Bull. 18 (1992) 209-215
26. Fannon D., Simmons A., Tennakoon L., O'Ceallaigh S., Sumich A., Doku V., Shew C., and Sharma T. Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia. Biol. Psychiatry 54 (2003) 587-598
27. Feinberg I. Schizophrenia and late maturational brain changes in man. Psychopharmacol. Bull. 18 (1982) 29-31
28. Frahm J., Merboldt K.D., and Haenicke W. Localized proton spectroscopy using stimulated echoes. J. Magn. Reson. 72 (1987) 502-508
29. Giedd J.N., Blumenthal J., Jeffries N.O., Castellanos F.X., Liu H., Zijdenbos A., Paus T., Evans A.C., and Rapoport J.L. Brain development during childhood and adolescence: a longitudinal MRI study. Nat. Neurosci. 2 (1999) 861-863
30. Gimenez M., Junque C., Perez M., Vendrell P., Baeza I., Salamero M., Mercader J.M., and Bernardo M. Basal ganglia N-acetylaspartate correlates with the performance in the procedural task 'Tower of Hanoi' of neuroleptic-naive schizophrenic patients. Neurosci. Lett. 347 (2003) 97-100
31. Gogtay N., Giedd J.N., Lusk L., Hayashi K.M., Greenstein D., Vaituzis A.C., Nugent III T.F., Herman D.H., Clasen L.S., Toga A.W., Rapoport J.L., and Thompson P.M. Dynamic mapping of human cortical development during childhood through early adulthood. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8174-8179
32. Huttenlocher P.R., and Dabholkar A.S. Regional differences in synaptogenesis in human cerebral cortex. J. Comp. Neurol. 387 (1997) 167-178
33. Huttenlocher P.R., deCourten C., Garey L.J., and van der Loos H. Synaptogenesis in human visual cortex-evidence for synapse elimination during normal development. Neurosci. Lett. 33 (1982) 247-252
34. Isohanni M., Isohanni I., Koponen H., Koskinen J., Laine P., Lauronen E., Miettunen J., Maki P., Riala K., Rasanen S., Saari K., Tienari P., Veijola J., and Murray G. Developmental precursors of psychosis. Curr. Psychiatry Rep. 6 (2004) 168-175
35. Keshavan M.S., Beckwith C., Bagwell W., Pettegrew J.W., and Krishnan K.R. An objective method for edge detection in M.R.I., morphometry. Eur. Psychiatr. 9 (1994) 205-207
36. Keshavan M.S., Anderson S., Beckwith C., Nash K., Pettegrew J., Ranga K., and Krishnan R.R. A comparison of stereology and segmentation techniques for volumetric measurements of lateral ventricles in magnetic resonance imaging. Psychiatry Res. 61 (1995) 53-60
37. Keshavan M.S., Stanley J.A., and Pettegrew J.W. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings-part. Biol. Psychiatry 48 (2000) 369-380
38. Keshavan M.S., Haas G., Miewald J., Montrose D.M., Reddy R., Schooler N.R., and Sweeney J.A. Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. Schizophr. Bull. 29 (2003) 757-769
39. Lipska B.K., and Weinberger D.R. A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus. Neurotox. Res. 4 (2002) 469-475
40. Manoach D.S., Press D.Z., Thangaraj V., Searl M.M., Goff D.C., Halpern E., Saper C.B., and Warach S. Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biol. Psychiatry 45 (1999) 1128-1137
41. McClellan J., McCurry C., Snell J., and DuBose A. Early-onset psychotic disorders: course and outcome over a 2-year period. J. Am. Acad. Child Adolesc. Psychiatry 38 (1999) 1380-1388
42. Mehler C., and Warnke A. Structural brain abnormalities specific to childhood-onset schizophrenia identified by neuroimaging techniques. J. Neural Transm. 109 (2002) 219-234
43. Molina V., Sanchez J., Reig S., Sanz J., Benito C., Santamarta C., Pascau J., Sarramea F., Gispert J.D., Misiego J.M., Palomo T., and Desco M. N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration. Schizophr. Res. 73 (2005) 209-219
44. Murray R.M., and Lewis S.W. Is schizophrenia a neurodevelopmental disorder?. Br. Med. J. 295 (1987) 681-682
45. Nicolson R., Brookner F.B., Lenane M., Gochman P., Ingraham L.J., Egan M.F., Kendler K.S., Pickar D., Weinberger D.R., and Rapoport J.L. Parental schizophrenia spectrum disorders in childhood-onset and adult-onset schizophrenia. Am. J. Psychiatry 160 (2003) 490-495
46. Ohrmann P., Siegmund A., Suslow T., Pedersen A., Spitzberg K., Kersting A., Rothermundt M., Arolt V., Heindel W., and Pfleiderer B. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. J. Psychiatr. Res. 41 (2007) 625-634
47. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia. NeuroImage 21 (2004) 1781-1789
48. Overall J.E., and Gorham D.R. The brief psychiatric rating scale. Psychol. Rep. 10 (1962) 428-437
49. Pettegrew J.W., Keshavan M.S., Panchalingam K., Strychor S., Kaplan D.B., Tretta M.G., and Allen M. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch. Gen. Psychiatry 48 (1991) 563-568
50. Pouwels P.J., Brockmann K., Kruse B., Wilken B., Wick M., Hanefeld F., and Frahm J. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr. Res. 46 (1999) 474-485
51. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 30 (1993.) 672-679
52. Rakic P., Bourgeois J.-P., Eckenhoff M.F., Zecevic N., and Goldman-Rakic P.S. Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex. Science 232 (1986) 232-235
53. Remschmidt H. Early-onset schizophrenia as a progressive-deteriorating developmental disorder: evidence from child psychiatry. J. Neural Transm. 109 (2002) 101-117
54. Ritsner M., Amir S., Koronyo-Hamaoui M., Gak E., Ziv H., Halperin T., Kitain L., and Navon R. Association study of CAG repeats in the KCNN3 gene in Israeli patients with major psychosis. Psychiatr. Genet. 13 (2003) 143-150
55. Ross C.A., and Pearlson G.D. Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach. Trends Neurosci. 19 (1996) 171-176
56. Seeger U., Klose U., Mader I., Grodd W., and Nagele T. Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases. Magn. Reson. Med. 49 (2003) 19-28
57. Selemon L.D., and Goldman-Rakic P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry 45 (1999) 17-25
58. Stanley J.A. In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders. Can. J. Psychiatry 47 (2002) 315-326
59. 1H MR spectra. Magn. Reson. Med. 34 (1995) 17-24
60. Stanley J.A., Williamson P.C., Drost D.J., Rylett R.J., Carr T.J., Malla A., and Thompson R.T. An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients. Schizophr. Bull. 22 (1996) 597-609
61. 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 30 (2005) 1949-1962
62. Theberge J., Bartha R., Drost D.J., Menon R.S., Malla A., Takhar J., Neufeld R.W., Rogers J., Pavlosky W., Schaefer B., Densmore M., Al-Semaan Y., and Williamson P.C. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am. J. Psychiatry 159 (2002) 1944-1946
63. 1H MR spectroscopy in childhood-onset schizophrenia. J. Magn. Reson. Imaging 8 (1998) 841-846
64. Thompson P.M., Vidal C., Giedd J.N., Gochman P., Blumenthal J., Nicolson R., Toga A.W., and Rapoport J.L. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 11650-11655
65. Urenjak J., Williams S.R., Gadian D.G., and Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13 (1993) 981-989
66. 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders. Ann. Neurol. 31 (1992) 202-211
67. Weinberger D.R. From neuropathology to neurodevelopment. Lancet 346 (1995) 552-557